Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6636244 | 0.98 | NPC1 (0.44) | NPC1RAB9ACYP3A4ALDH1A1HPGD | |
| SCHEMBL3798990 | 0.76 | CYP1A2 (0.41) | NPC1RAB9ACYP3A4TDP1SMN1; SMN2 | |
| SCHEMBL5424464 | 0.71 | MEN1 (0.38) | NPC1RAB9ACYP3A4TDP1SMN1; SMN2 | |
| SCHEMBL2007380 | 0.71 | MEN1 (0.38) | NPC1RAB9ACYP3A4TDP1SMN1; SMN2 | |
| SCHEMBL6261842 | 0.71 | ADORA2A (0.42) | NPC1RAB9ACYP3A4ALDH1A1HPGD | |
| SCHEMBL104411 | 0.71 | MEN1 (0.38) | NPC1RAB9ACYP3A4TDP1SMN1; SMN2 | |
| SCHEMBL276858 | 0.71 | MEN1 (0.38) | NPC1RAB9ACYP3A4TDP1SMN1; SMN2 | |
| SCHEMBL288995 | 0.71 | MEN1 (0.38) | NPC1RAB9ACYP3A4TDP1SMN1; SMN2 | |
| SCHEMBL276859 | 0.71 | ADORA2A (0.42) | NPC1RAB9ACYP3A4ALDH1A1HPGD | |
| SCHEMBL2589546 | 0.71 | MEN1 (0.38) | NPC1RAB9ACYP3A4TDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400591-A1 | COMPOUNDS TARGETING MUTANT OF P53 | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2024-12-05 | — | — | US | claimed |
| CN-118507514-B | Preparation method of longitudinal beta gallium oxide NPN transistor | 深圳市港祥辉电子有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118507514-A | Preparation method of longitudinal beta gallium oxide NPN transistor | 深圳市港祥辉电子有限公司 | 2024-08-16 | — | — | CN | claimed |
| WO-2026090348-A1 | THE USE OF SON OF SEVENLESS (SOS) INHIBITOR COMPOUNDS SUCH AS 7-SUBSTITUTED BENZOFURANS TO TREAT CANCER | Mirati Therapeutics, Inc. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20250214948-A1 | TRIAZINE DERIVATIVES FOR TREATING DISEASES RELATING TO NEUROTROPHINS | AlzeCure Pharma AB (SE) | 2025-07-03 | — | — | US | disclosed |
| US-20240400591-A1 | COMPOUNDS TARGETING MUTANT OF P53 | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2024-12-05 | — | — | US | disclosed |
| CN-118507514-B | Preparation method of longitudinal beta gallium oxide NPN transistor | 深圳市港祥辉电子有限公司 | 2024-11-01 | — | — | CN | disclosed |
| CN-118507514-A | Preparation method of longitudinal beta gallium oxide NPN transistor | 深圳市港祥辉电子有限公司 | 2024-08-16 | — | — | CN | disclosed |
| US-20240246908-A1 | TEAD INHIBITORS | ORION CORPORATION (FI) | 2024-07-25 | — | — | US | disclosed |
| EP-4395520-A2 | LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2024-07-03 | — | — | EP | disclosed |
| EP-3862360-B1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2024-07-03 | — | — | EP | disclosed |
| EP-0490772-A1 | 1,4-Disubstituted piperazines, their process of preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1992-06-17 | — | — | EP | disclosed |
| US-5068359-A | Fungicides of benzothiophene and benzofuran compounds | CIBA-GEIGY CORPORATION (US) | 1991-11-26 | — | — | US | disclosed |
| EP-0079683-B1 | HERBICIDAL SULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-05-06 | — | — | EP | disclosed |
| US-4647677-A | Process for preparing 2,3-dihydro-7-aminobenzofurans | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1987-03-03 | — | — | US | disclosed |
| US-4514211-A | HERBICIDES, PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-04-30 | — | — | US | disclosed |
| US-4398028-A | HYPOTENSIVE, MUSCLE RELAXANTS | SANDOZ LTD. (CH) | 1983-08-09 | — | — | US | disclosed |
| EP-0079683-A2 | Herbicidal sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-05-25 | — | — | EP | disclosed |
| US-4297490-A | HYPOTENSIVE AND ANTISPASMODIC AGENTS | SANDOZ LTD. (CH) | 1981-10-27 | — | — | US | disclosed |
| US-4077953-A | Tri-dentate metal complex azo pigments | CIBA-GEIGY CORPORATION (US) | 1978-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214948-A1 | TRIAZINE DERIVATIVES FOR TREATING DISEASES RELATING TO NEUROTROPHINS | NTRK2, BDNF, NGF | NPC1 1016/4885RAB9A 3039/4885CYP3A4 4531/4885 |
| US-20240246908-A1 | TEAD INHIBITORS | TEAD3, TEAD1, TEAD2 | NPC1 783/4885RAB9A 112/4885CYP3A4 1748/4885 |
| US-20240400591-A1 | COMPOUNDS TARGETING MUTANT OF P53 | TP53, TP53BP1, MDM2 | NPC1 1540/4885RAB9A 2731/4885CYP3A4 4371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.